Skip to Content

MoxDuo Approval Status

  • FDA approved: No
  • Brand name: MoxDuo
  • Generic name: morphine and oxycodone
  • Company: QRxPharma Limited
  • Treatment for: Pain

MoxDuo (morphine and oxycodone) is a narcotic analgesic combination in development for the treatment of moderate to severe acute pain.

Development Status and FDA Approval Process for MoxDuo

Apr 22, 2014QRxPharma Issues Statement On Moxduo Advisory Committee Meeting
Dec 11, 2013QRxPharma Announces 25 May 2014 as New PDUFA Date for MoxDuo NDA
Nov 26, 2013QRxPharma Refiles MoxDuo New Drug Application with the FDA
Aug 28, 2013QRxPharma Receives Complete Response Letter From FDA Regarding MoxDuo NDA
Mar 14, 2013FDA Sets 26 August 2013 As New PDUFA Date For MoxDuo NDA
Feb 28, 2013QRxPharma Resubmits MoxDuo New Drug Application to the FDA
Jan 16, 2013QRxPharma and FDA Establish Path Forward for Resubmission Of Moxduo New Drug Application
Jun 27, 2012QRxPharma Receives Complete Response Letter From FDA Regarding MoxDuo NDA
Nov 11, 2011QRxPharma Granted Target Date for FDA Action on MoxDuo IR NDA: NDA Accepted for Review; PDUFA Date Set for June 25, 2012
Aug 26, 2011QRxPharma Completes NDA Submission for MoxDuo IR
Jul 19, 2011QRxPharma Announces NDA Filing for MoxDuo IR

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.